<DOC>
	<DOC>NCT01709318</DOC>
	<brief_summary>The study is designed to the evaluate ovulation inhibition, vaginal bleeding, and pharmacokinetics associated with three different doses of two next generation vaginal rings (NGRs), identifying at least one whose control of menstrual cycles is not inferior to that of NuvaRing®.</brief_summary>
	<brief_title>A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012)</brief_title>
	<detailed_description />
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<criteria>Body mass index (BMI) ≥18 and ≤35 Regular cycles from 24 to 35 days in length, with an intraindividual variation of ±3 days permitted within this range Good physical and mental health Diabetes mellitus with vascular involvement Presence of a severe or multiple risk factor(s) for venous or arterial thrombosis Severe dyslipoproteinemia Severe hypertension Presence or history of pancreatitis associated with severe hypertriglyceridaemia Presence or history of severe hepatic disease Undiagnosed vaginal bleeding Known or suspected pregnancy Participation in another investigational drug study within 30 days prior to screening visit History of malignancy ≤5 years, except for adequately treated basal cell or squamous cell skin cancer, or in situ cervical cancer Documented abnormal cervical smear result in 6 months prior to screening visit Sterilization using using a fallopian tube occlusion device (e.g., Essure method) Sex hormone therapy within 2 months prior to screening visit for purpose other than contraception, or injectable hormonal contraception within 6 months prior to screening</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>